ABOUT STARTX
StartX, and StartX Med, the medical vertical of StartX, is a non-profit startup community of more than 1600 Stanford faculty and alumni founders. For medical tech founders homegrown at Stanford’s School of Medicine, having intimate access to domain experts and care environments has been fundamental to their success. StartX Med's entrepreneurial scientists are changing the world with medical breakthroughs and successful life-saving research, including driving innovations in COVID-19 through the work of its Task Force. The community averages a minimum of 6+ FDA approvals / clearances per year. Clinical partners of StartX Med companies encompass more than 250 hospitals, 30,000 care centers, 50,000 physicians and 65 million annual patient visits. StartX Med founders also have the opportunity to utilize 2,000 square feet of shared wet lab space at the StartX facility, located down the street from Stanford University. StartX continues to be a unique, equity-free startup community.
The StartX community has over $7B in capital raised, 80 exits, and $26B in market capitalization created during the past decade alone. The community includes a former EIR at Kleiner Perkins, EIR at MPM Capital, Head of McKinsey's Healthcare Group, a founder with exits to Roche and J&J respectively, and over 60 Stanford Professors, to highlight a few of the bright pioneers' backgrounds who are creating new innovations for patients at StartX Med.
ABOUT ADVAMED
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies.
Back to HCB News
